FAKTOR-OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000SD418X2

Real-time Boerse Frankfurt Warrants 12:43:50 2024-07-17 pm EDT
0.031 EUR -38.00% Intraday chart for FAKTOR-OPTIONSSCHEIN - MEDTRONIC
1 month+25.00%
3 months-25.37%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-17 0.031 -38.00%
24-07-16 0.05 -9.09%
24-07-15 0.055 +10.00%
24-07-12 0.05 -3.85%
24-07-11 0.052 -14.75%

Real-time Boerse Frankfurt Warrants

Last update July 17, 2024 at 12:43 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SD418X
ISINDE000SD418X2
Date issued 2021-03-29
Strike 116.7 $
Maturity Unlimited
Parity 1 : 1
Emission price 8.45
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.06
Lowest since issue 0.023
Spread 0.01
Spread %23.26%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.1 USD
Average target price
93.24 USD
Spread / Average Target
+19.38%
Consensus